Covington has advised OrbiMed. Goodwin Procter has advised Intellia Therapeutics. OrbiMed, a global healthcare investment firm, has entered into a non-dilutive senior secured term loan facility...
OrbiMed Provides $400 Million Non-Dilutive Debt Facility to Intellia Therapeutics
Catalio Capital Management Makes $38 Million Strategic Investment in ProSomnus
Covington has advised Catalio Capital Management LP. Catalio Capital Management LP has made a strategic investment of up to $38 million in ProSomnus Sleep Technologies, aiming...
TapestryHealth’s $25 Million Term Loan Financing
Covington & Burling LLP represented Catalio Capital Management, LP in the deal. TapestryHealth announced $25 million credit investment from Catalio Capital Management (“Catalio”). The term loan is an...
OrbiMed’s $75 Million Debt Financing
Covington advised OrbiMed on the deal. An investment fund affiliated with OrbiMed Advisors announced a $75 million delayed draw senior secured loan to be provided to...
Caris Life Sciences’ $400 Million Secured Debt Financing
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...